Peripheral T cell lymphoma not otherwise specified induced by fingolimod treatment for multiple sclerosis
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz343.016
Abstract: Abstract Introduction Fingolimod is a sphingosine-1-phosphate (S1P) receptor modulator that prevents B and T lymphocyte egress from the lymph nodes, and reduces peripheral lymphocyte counts and entry of lymphocytes into the central nervous system. In… read more here.
Keywords: fingolimod treatment; treatment; induced fingolimod; multiple sclerosis ... See more keywords